Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors

Cellular immunotherapies represent a promising approach for the treatment of cancer. Engineered adoptive cell therapies redirect and augment a leukocyte’s inherent ability to mount an immune response by introducing novel anti-tumor capabilities and targeting moieties. A prominent example of this app...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Christopher Sloas, Saar Gill, Michael Klichinsky
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/00815eb322fe41ae977bcde18dd243c7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!